H19 and neoplasm: Zhang Y et al., intravenously injected exosomal H19 into a mouse xenograft pituitary tumor model, which reduced the tumor volume and increased its sensitivity to cabergoline, a common therapeutic agent used for the therapy of lactotroph PitNETs [140].